QUICK READ: The MedAd News Manny Awards were last night. Congratulations to the winners, but the bar has been set higher if pharma is to really demonstrate they care about patients. Award winners should see their awards as a head nod and understand they have a LOT more work to do.
QUICK READ: According to Setup 30% of Brand marketers say they’re likely/somewhat likely to switch Agencies in the next 6 months. While the consolidation of agencies may be a priority for some pharma companies a good digital agency can add a lot of value. There is a lot of downside to letting your main ad agency do your digital work.
QUICK READ: Changes are on the horizon for healthcare and pharma, yet very few pharma companies are prepared for the changes that are coming. People within the pharma industry are still caught in back-to-back meetings that last all day, and decision-making, even for simple things, can take weeks and months.
IN BRIEF: As a marketer, most of us, like a Jungian archetype, are true Communicators. Yet are those skills only reserved for big budgets, bold pitches, and grand innovations? Or do we, as individuals, have a special responsibility to the public at this moment in time? After all, we are already the translators of science for our clients.
SUMMARY: Almost every pharma company seems to be posting open digital marketing positions on LinkedIn but are they really hiring? A quick check of three open positions found that they “were on hold” due to budget constraints.
SUMMARY: There are some excellent digital agencies dedicated to pharma. Greater-Than-One and InTouch Solutions are just a couple. Agencies have experience in leading and developing cutting-edge digital pharma marketing solutions, but they need your help to really be effective.
SUMMARY: The industry is facing several challenges on several fronts. Amgen is laying off people because of their poor financial outlook. Merck’s old drugs are under more scrutiny, and anti-vaxxers are causing problems by cherry-picking unreliable information.
SUMMARY: The biggest threat to the pharma industry isn’t the coming tsunami of healthcare changes. It’s reshaping the company to once again focus on patients instead of profits.